metformin has been researched along with Pulmonary Arterial Hypertension in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Pulmonary Arterial Hypertension: A progressive rare pulmonary disease characterized by high blood pressure in the PULMONARY ARTERY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Previous studies have shown that metformin (MET) prevents experimental pulmonary arterial hypertension (PAH) and that activation of autophagy is involved in the development of pulmonary vascular remodeling." | 3.91 | Metformin Prevents Progression of Experimental Pulmonary Hypertension via Inhibition of Autophagy and Activation of Adenosine Monophosphate-Activated Protein Kinase. ( Li, H; Liu, Y; Sun, Z; Xu, Y; Yang, G; Zhang, J; Zhu, J, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, Y | 1 |
| Xu, Y | 1 |
| Zhu, J | 1 |
| Li, H | 1 |
| Zhang, J | 1 |
| Yang, G | 1 |
| Sun, Z | 1 |
1 other study available for metformin and Pulmonary Arterial Hypertension
| Article | Year |
|---|---|
Metformin Prevents Progression of Experimental Pulmonary Hypertension via Inhibition of Autophagy and Activation of Adenosine Monophosphate-Activated Protein Kinase.
Topics: AMP-Activated Protein Kinases; Animals; Autophagy; Autophagy-Related Proteins; Cells, Cultured; Dise | 2019 |